These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3271378)

  • 1. [Polychemotherapy of leprosy in a rural area].
    Languillon J
    Acta Leprol; 1988; 6(5):67-71. PubMed ID: 3271378
    [No Abstract]   [Full Text] [Related]  

  • 2. [Practical problems of polychemotherapy of leprosy in the Ivory Coast].
    N'Deli N; Konian K
    Acta Leprol; 1986; 4(3):373-7. PubMed ID: 3031921
    [No Abstract]   [Full Text] [Related]  

  • 3. [Guinea: detection of leprosy and treatment by polychemotherapy].
    Bourée P; Carré N; Drahmane S
    Bull Soc Pathol Exot Filiales; 1988; 81(4):683-91. PubMed ID: 3219772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance and multi-drug therapy in leprosy.
    Chatterjee BR
    Indian J Lepr; 1989 Jul; 61(3):328-32. PubMed ID: 2768881
    [No Abstract]   [Full Text] [Related]  

  • 5. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
    Sansarricq H
    Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
    [No Abstract]   [Full Text] [Related]  

  • 8. A century of progress in the therapy of leprosy.
    Karat AB; Ramanujam K
    Int J Lepr Other Mycobact Dis; 1973; 41(3):382-91. PubMed ID: 4130572
    [No Abstract]   [Full Text] [Related]  

  • 9. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 10. The future of leprosy in the Dominican Republic: experience with multidrug therapy.
    Martinez Cruz D
    Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953
    [No Abstract]   [Full Text] [Related]  

  • 11. [Polychemotherapy of leprosy in the Central African Republic, 1987].
    Desfontaine M; Somse P; Baquillon G; Kanda P; Limbassa J
    Acta Leprol; 1988; 6(5):47-55. PubMed ID: 3271377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 13. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
    Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined treatments consisting of rifampicin in periodic doses: the experience in Niger].
    Soga G; Blanc L; Alfa C; Grosset J; Xavier S
    Acta Leprol; 1986; 4(4):397-407. PubMed ID: 3296609
    [No Abstract]   [Full Text] [Related]  

  • 15. Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study.
    Kumar B; Kaur S; Kaur I
    Indian J Lepr; 1987; 59(1):54-62. PubMed ID: 3302061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Employment of a program in the leprosy campaign in Mayotte based on the use of rifampicin and clofazimine].
    Blanchy S; Galtier J
    Acta Leprol; 1982; (88):19-22. PubMed ID: 6818815
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro immunologic changes in 4 patients with lepromatous leprosy treated for 1 year with rifampicin and sulfones and left untreated the following year].
    Saint-André P
    Acta Leprol; 1979; (76-77):301-2. PubMed ID: 121849
    [No Abstract]   [Full Text] [Related]  

  • 18. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
    Paul S; Rose ET
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of neuritis in borderline leprosy with rifampicin and corticosteroids--a pilot trial.
    Steenbergen GJ; Pfaltzgraff RE
    Lepr Rev; 1975 Jun; 46(2):115-8. PubMed ID: 1160473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.